Literature DB >> 7351776

Tamoxifen and thromboembolism.

A Hendrick, V P Subramanian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7351776

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.

Authors:  G Bertelli; P Pronzato; D Amoroso; M P Cusimano; P F Conte; G Montagna; S Bertolini; R Rosso
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

2.  Clinical and biomarker predictors of side effects from tamoxifen.

Authors:  Wendy Lorizio; Alan H B Wu; Mary S Beattie; Hope Rugo; Simone Tchu; Karla Kerlikowske; Elad Ziv
Journal:  Breast Cancer Res Treat       Date:  2011-12-30       Impact factor: 4.872

3.  Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.

Authors:  Fang-Fang Gao; Jia-Wei Lv; Ying Wang; Rong Fan; Qun Li; Zun Zhang; Lei Wei
Journal:  Biomed Rep       Date:  2015-10-30

Review 4.  Antiestrogens--tamoxifen, SERMs and beyond.

Authors:  K Dhingra
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  Chemotherapy enhances endothelial cell reactivity to platelets.

Authors:  M C Bertomeu; S Gallo; D Lauri; M N Levine; F W Orr; M R Buchanan
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

6.  The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation.

Authors:  Zhixiang Hao; Jiahao Xu; Han Zhao; Wei Zhou; Zhao Liu; Shiqing He; Xiaoxing Yin; Bei Zhang; Zhongjian Wang; Xueyan Zhou
Journal:  BMC Pharmacol Toxicol       Date:  2022-05-31       Impact factor: 2.605

Review 7.  Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 8.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

9.  Tamoxifen and risk of idiopathic venous thromboembolism.

Authors:  C R Meier; H Jick
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

Review 10.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.